Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: Implications for age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 5, 2005, Pages 1765-1773

  Miceli, Michael V ^a   Jazwinski, S Michal ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; APOLIPOPROTEIN E; BETA5 INTEGRIN; CD51 ANTIGEN; CD97 ANTIGEN; CLUSTERIN; COLLAGEN TYPE 1; COLLAGEN TYPE 5; EPOXIDE HYDROLASE; ETHIDIUM BROMIDE; FIBROBLAST GROWTH FACTOR 5; FIBULIN; GELATINASE A; GLUTATHIONE TRANSFERASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; PROTEIN LYSINE 6 OXIDASE; SCAVENGER RECEPTOR BI; TERT BUTYL HYDROPEROXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; URIDINE; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VITRONECTIN; 5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLOCARBOCYANINE; 5,5',6,6'-TETRACHLORO-1,1',3,3'-TETRAETHYLBENZIMIDAZOLOCARBOCYANINE; BENZIMIDAZOLE DERIVATIVE; CARBOCYANINE; ETHIDIUM; FLUORESCENT DYE; NUCLEAR PROTEIN;

ARTICLE; AUXOTROPHY; BASEMENT MEMBRANE; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DNA ISOLATION; DRUSEN; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID TRANSPORT; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PHASE CONTRAST MICROSCOPY; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; CELL CULTURE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION;

BENZIMIDAZOLES; CARBOCYANINES; CELL SURVIVAL; CELLS, CULTURED; DNA, MITOCHONDRIAL; DOWN-REGULATION; ETHIDIUM; FLUORESCENT DYES; GENE EXPRESSION REGULATION; HUMANS; MACULAR DEGENERATION; MEMBRANE POTENTIALS; MITOCHONDRIAL DISEASES; NUCLEAR PROTEINS; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TERT-BUTYLHYDROPEROXIDE;

EID: 20444483650     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1327     Document Type: Article

References (64)

1. Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969;42: 392-403.
2. Bok D, Hall MO. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol. 1971;49:664-682.
3. Hogan MJ. Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:64-80.
4. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31:291-306.
5. Klein R, Klein BE, Linton KL. Prevalence of age related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
6. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. Epidemiology of age-related maculopathy: a review. Eur J Epidemiol. 2003;18:845-854.
7. Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results. Arch Ophthalmol. 2003;121:1621-1624.
8. Eldred GE. Retinoid reaction products in age related retinal degeneration. Hollyfield JG, Anderson RE, LaVail MM, eds. Retinal Degeneration: Clinical and Laboratory Manifestations. New York: Plenum Press; 1993:15-24.
9. Van der Schaft TL, Mooy CM, de Bruijn WC, de Jong, PTVM. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol. 1993;77: 657-661.
10. Sarks SH. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol. 1982;10:91-97.
11. Bressler MN, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14: 130-142.
12. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:265-274.
13. Green WR. Histopathology of age-related macular degeneration. Mol Vis. 1999;5:27.
14. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44:S10-S32.
15. Sarks SH. Ageing and degeneration in the macular region: a clinicopathological study, Br J Ophthalmol. 1976;60:324-341.
16. Zarbin MA. Age-related macular degeneration: review of pathogenesis. Eur J Ophthalmol. 1998;8:199-206.
17. Dunaief JL, Dentchav T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120: 1435-1442.
18. Traven A, Wong JM, Xu D, Sopta M, Ingles CJ. Interorganellar communication: altered nuclear gene expression profiles in a yeast mitochondrial DNA mutant. J Biol Chem. 2001;276:4020-4027.
19. Butow RA. Cellular responses to mitochondrial dysfunction: it's not always downhill. Cell Death Differ. 2002;9:1043-1045.
20. Kirchman PA, Kim S, Lai CY, Jazwinski SM. Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics. 1999;152:179-190.
21. Borghouts C, Benguria A, Wawryn J, Jazwinski SM. Rtg2 protein links metabolism and genome stability in yeast longevity. Genetics. 2004;16:765-777.
22. Biswas G, Adebanjo OA, Freedman BD, et al. Retrograde Ca2 + signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 1999;18:522-533.
23. Butow RA, Avadhani NG. Mitochondrial signaling: the retrograde response. Mol Cell. 2004;14:1-15.
24. Miceli MV, Jazwinski SM. Common and cell type-specific responses of human cells to mitochondrial dysfunction. Exp Cell Res. 2005; 302:270-280.
25. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related disease. Exp Eye Res. 2003; 76:397-403.
26. Feher J, Papale A, Mannino G, Gualdi L, Gabriell CB. Mitotropic compounds for the treatment of age-related macular degeneration. Ophthalmologica. 2003;217:351-357.
27. Dunn KC, Aotaki-Keen AE, Putkey F, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
28. King MP, Attardi G. Isolation of human cell lines lacking mitochondrial DNA. Methods Enzymol. 1996;264:304-313.
29. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6″- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (TC-1). Biochem Biophys Res Commun. 1993;197: 40-45.
30. Miceli MV, Newsome DA, Tate DJ Jr. Vitronectin is responsible for serum-stimulated uptake of rod outer segments by cultured retinal pigment epithelial cells. Invest Ophtbalmol Vis Sci. 1997;38: 1588-1597.
31. Finnemann SC. Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors. EMBO J. 2003;22:4143-4154.
32. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682-14687.
33. Blackburn J, Tarttelin EE, Gregory-Evans CY, Moosajee M, Gregory-Evans K. Transcriptional regulation and expression of the dominant drusen gene FBLN3 (EFEMP1) in mammalian retina. Invest Ophthalmol Vis Sci. 2003;44:4613-4621.
34. Hageman GS, Mullins RF, Russell SR, Johnson LV, Anderson DH. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J. 1999;13:477-484.
35. Kimoto K, Nakattsuka K, Matsuo N, Yoshioka H. p38 MAPK mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells ARPE-19. Invest Ophthalmol Vis Sci. 2004;45:2431-2437.
36. Scheiffarth OF, Kampik A, Gunther H, von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol. 1988;226:357-361.
37. Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, Rakcozy E. Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res. 2000;21:684-690.
38. Elner SG. Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase and elastase. Trans Am Ophthalmol Soc. 2002;100:273-299.
39. Rakic JM, Lambert V, Munaut C, et al. Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:1732-1739.
40. Omori K, Fujiseki Y, Omori K, Suzkawa J, Inagaki C. Regulation of the expression of lysyl oxidase mRNA in cultured rabbit retinal pigment epithelium cells. Matrix Biol. 2002;21:337-348.
41. Kamei M, Hollyfield JG. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1999;40:2367-2375.
42. Anderson DH, Ozaki S, Nealon M, et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol. 2001;131:767-781.
43. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003;162: 413-425.
44. Heckenlively JR, Hawes NL, Friedlander M, et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina. 2003;23:518-522.
45. Elner SG, Elner VM, Nielsen JC, Torczynski E, Yu R, Franklin WA. CD68 antigen expression by human retinal pigment epithelial cells. Exp Eye Res. 1992;55:21-28.
46. Duncan KG, Bailey KR, Kane JP, Schwartz DM. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem Biophys Res Commun. 2002;292:1017-1022.
47. Hayes KC, Lindsey S, Stephan ZF, Brecker D. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci. 1989;30:225-232.
48. Mitsuhiro MR, Eguchi S, Yamashita H. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily. Acta Ophthalmol Scand. 2003;81:630-638.
49. Kitaoka T, Morse LS, Schneeberger S, Ishigooka H, Hjelmeland LM. Expression of FGF5 in choroidal neovascular membranes associated with ARMD. Cur Eye Res. 1997;16:396-399.
50. Gray JX, Haino M, Roth MJ, et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol. 1996;157:5438-5447.
51. Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158-3148.
52. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese Superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol. 2000;130:769-773.
53. Strunnkikova N, Zhang C, Teichberg, et al. Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004;45:3767-3777.
54. Miceli MV, Newsome DA. Cultured retinal pigment epithelium cells from donors with type I diabetes show an altered insulin response. Invest Ophthalmol Vis Sci. 1991;32:2847-2853.
55. Tyni T, Johnson M, Eaton S, Pourfarzam M, Andrews R, Turnbull DM. Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium. Pediatr Res. 2002;52:595-600.
56. Ozaki S, Johnson LV, Mullins RF, Hageman GS, Anderson DH. The human retina and retinal pigment epithelium are abundant sources of vitronectin mRNA. Biochem Biophys Res Commun. 1999;258: 524-529.
57. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Trans-differentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37:855-868.
58. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
59. Mullie MA, Harding AE, Petty RK, Ikeda H, Morgan-Hughes JA, Sanders MD. The retinal manifestations of mitochondrial myopathy: a study of 22 cases. Arch Ophthalmol. 1985;103:1825-1830.
60. Isashiki Y, Nakagawa M, Ohba N, et al. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand. 1998;76:6-13.
61. Barga G. Free radicals and aging. Trends Neurosci. 2004;27:595-600.
62. Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis. Biochem Biophys Res Commun. 2003;304:519-529.
63. Newsome DA, Miceli MV, Tate DJ Jr, Alcock NW, Oliver PD. Zinc content of human retinal pigment epithelium decreases with age and macular degeneration, but Superoxide dismutase increases. J Trace Elem Exp Med. 1995;8:193-199.
64. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003;161:41-54.